BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Chubb
Teva
McKinsey
Chinese Patent Office
Argus Health
Harvard Business School
Julphar
Daiichi Sankyo

Generated: January 17, 2018

DrugPatentWatch Database Preview

SULFAMETHOXAZOLE Drug Profile

« Back to Dashboard

When do Sulfamethoxazole patents expire, and when can generic versions of Sulfamethoxazole launch?

Sulfamethoxazole is a drug marketed by Ascot, Aurolife Pharma Llc, Barr, Heather, Watson Labs, Abraxis Pharm, Bedford, Hospira, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Ani Pharms Inc, Aurobindo Pharma, Hi Tech Pharma, Teva, Vintage, Amneal Pharms Ny, Chartwell Molecules, Glenmark Generics, Interpharm, Martec Usa Llc, Mutual Pharm, Pliva, Roxane, Sandoz, Sun Pharm Industries, Usl Pharma, Vista Pharms, Able, and Teva Pharms. and is included in fifty NDAs.

The generic ingredient in SULFAMETHOXAZOLE is phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim profile page.

US Patents and Regulatory Information for SULFAMETHOXAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 070890-001 Nov 13, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Interpharm SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 071299-001 Oct 27, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vista Pharms SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 076817-002 Oct 7, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 070030-001 Jun 2, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 018242-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 070002-001 Nov 7, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mutual Pharm SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 070007-001 Nov 14, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 090828-002 Dec 22, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Interpharm SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 071300-001 Oct 27, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 090828-001 Dec 22, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
UBS
Healthtrust
Dow
Johnson and Johnson
Covington
Cerilliant
Deloitte
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot